SSG
GILD icon

Summit Securities Group’s Gilead Sciences GILD Stock Holding History

Summit Securities Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-14,800
Closed -$1.27M – 999
2022
Q4 		$1.27M Buy
+14,800
New +$1.17M 0.05% 155
2022
Q2 		– Sell
-10,000
Closed -$595K – 1060
2022
Q1 		$595K Sell
10,000
-96,100
-91% -$6.14M 0.07% 206
2021
Q4 		$7.7M Buy
106,100
+105,752
+30,389% +$7.28M 0.36% 55
2021
Q3 		$2.43M Sell
348
-270
-44% -$19K 0.19% 126
2021
Q2 		$4.26M Buy
618
+368
+147% +$24.6K 0.35% 58
2021
Q1 		$1.62M Sell
250
-110
-31% -$7.09K 0.18% 126
2020
Q4 		$2.1M Sell
360
-278
-44% -$16.8K 0.18% 137
2020
Q3 		$4.03M Buy
638
+338
+113% +$23.4K 0.42% 47
2020
Q2 		$2.31M Buy
300
+100
+50% +$7.66K 0.29% 75
2020
Q1 		$1.5M Sell
200
-246
-55% -$17K 0.26% 84
2019
Q4 		$2.9M Buy
+446
New +$29K 0.22% 107
2019
Q2 		– Sell
-385
Closed -$2.5M – 349
2019
Q1 		$2.5M Buy
385
+44
+13% +$2.92K 0.46% 45
2018
Q4 		$2.13M Buy
+341
New +$23.8K 0.18% 83
2018
Q3 		– Sell
-48
Closed -$340K – 221
2018
Q2 		$340K Buy
48
+3
+7% +$212 0.05% 160
2018
Q1 		$339K Buy
+45
New +$3.58K 0.08% 109
2017
Q4 		– Sell
-32
Closed -$259K – 208
2017
Q3 		$259K Sell
32
-5
-14% -$382 0.04% 159
2017
Q2 		$262K Buy
+37
New +$2.46K 0.05% 165
2017
Q1 		– Sell
-265
Closed -$1.9M – 331
2016
Q4 		$1.9M Buy
+265
New +$19.7K 0.41% 51
2016
Q1 		– Sell
-568
Closed -$2K – 221
2015
Q4 		$2K Buy
568
+102
+22% +$10.6K ﹤0.01% 257
2015
Q3 		$981K Buy
+466
New +$51.8K 0.71% 28

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Summit Securities Group's GILD Position: Q1 2026 in Review

Summit Securities Group sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 18,432 shares — an estimated $2.26M sold.

Summit Securities Group first reported a position in GILD in Q3 2013 and held it in 42 quarters. The position peaked at $16.9M in Q2 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Summit Securities Group reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • Summit Securities Group sold 18,432 Gilead Sciences shares in Q1 2026, an estimated $2.26M.
  • Summit Securities Group first reported a position in Gilead Sciences in Q3 2013 and held it in 42 quarters.
  • Summit Securities Group's Gilead Sciences position peaked at $16.9M in Q2 2015.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.